Brevibacillus laterosporus isolated from the digestive tract of honeybees has high antimicrobial activity and promotes growth and productivity of honeybee’s colonies
The development of novel antimicrobial drugs, as well as the discovery of novel compounds able to promote honeybee’s growth, represents major challenges for modern entomology. The main aim of this study was to investigate whether Brevibacillus laterosporus isolated from the digestive tract of Saudi honeybees, Apis mellifera, was able to stimulate colony strength parameters of honeybees and to evaluate its ability to produce antimicrobial agents. Honeybees were collected in Dirab, Riyadh Region, Saudi Arabia, and microorganisms were isolated and identified by 16S ribosomal RNA analysis. Microscopic identification of the microorganism in its native state was facilitated by atomic force microscopy at high-resolution imaging. Active biological compounds were produced by submerged fermentation with B. laterosporus. The fermented broth was subjected to extraction and purification, and then semi-pure compounds were analyzed by gas chromatography–mass spectrometry. The effectiveness of the crude extract and semi-pure compounds as antimicrobial agents was evaluated by susceptibility assays. More than 22% of the microorganisms isolated from the digestive tract of healthy honeybees have been identified as B. laterosporus, this kind of species has a unique shape and morphological structure. The cyclic dipeptide cyclo(Leu-Pro) produced by B. laterosporus showed biological activity against several pathogenic microorganisms. Furthermore, the total counts of workers, closed brood, and open brood, as well as the production of bee pollen and honey, were better in honeybees treated with a B. laterosporus suspension. The data indicated that the B. laterosporus strain isolated from a healthy honeybee might be a novel probiotic and a producer of important biological compounds.
KeywordsBrevibacillus laterosporus Honey production Pollen production Open brood Probiotic Antimicrobial agents
This project was funded by (KACST) King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number (LGP-34-112).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- Alharbi NS, Khaled JM, Alzaharni KE, Mothana RA, Alsaid MS, Alhoshan M, Dass LA, Kadaikunnan S, Alobaidi AS (2017) Effects of Piper cubeba L essential oil on methicillin-resistant Staphylococcus aureus: an AFM and TEM study. J Mol Recognit 30Google Scholar
- Benelli G (2017) Plant-borne compounds and nanoparticles: challenges for medicine, parasitology and entomology—GREEN-NANO-PEST&DRUGS. Environ Sci Pollut Res. https://doi.org/10.1007/s11356-017-9960-y
- Biavati B, Castagnoli P, Crociani F, Trovatelli L (1984) Species of the Bifidobacterium in the feces of infants. Microbiologica 7:341Google Scholar
- Graz M, Hunt A, Jamie H, Grant G, Milne P (1999) Antimicrobial activity of selected cyclic dipeptides. Die Pharmazie 54:772–775Google Scholar
- Hudzicki J (2009) Kirby-Bauer disk diffusion susceptibility test protocol. American Society for MicrobiolGoogle Scholar
- Shida O, Takagi H, Kadowaki K, Komagata K (1996) Proposal for two new genera, Brevibacillus gen nov and Aneurinibacillus gen nov. Int J Syst Evol Microbiol 46:939–946Google Scholar
- Winston ML (1991) The biology of the honey bee. Harvard University PressGoogle Scholar